SPDR S&P Biotech (XBI)

Add to Watchlists
Create an Alert
253.22 -5.72  -2.21% NYSE Arca Jul 29, 17:00 Delayed 2m USD
View Full Chart
XBI Price Chart

XBI Description

SPDR S&P Biotech is a long only equity fund managed by SPDR State Street Global Advisors that tracks the S&P Biotechnology Select Industry TR USD index and has 2.947B USD assets under management. It has an forecasted dividend yield of 0.03%, a forecasted PE ratio of 34.19, and a forecasted price to book value of 6.331. The fund has a net expense ratio of 0.35%, turns over its positions 86.00% per year, and is traded on the New York Stock Exchange Arca.

XBI Key Info

Expense Ratio (2-3-15) 0.35%
Assets Under Management (7-28-15) 2.947B
30-Day Average Volume (7-28-15) 1.334M
Net Asset Value (7-28-15) 258.51
Discount or Premium to NAV (7-28-15) 0.17%
Turnover Ratio (6-30-14) 86.00%

XBI Asset Allocation

Type % Net % Long % Short
Cash 0.09% 0.09% 0.00%
Stock 99.91% 99.91% 0.00%
Bond 0.00% 0.00% 0.00%
Convertible 0.00% 0.00% 0.00%
Preferred 0.00% 0.00% 0.00%
Other 0.00% 0.00% 0.00%
As of July 27, 2015

XBI Region Exposure

Americas 98.70%
North America 98.70%
Latin America 0.00%
Greater Europe 1.30%
United Kingdom 0.00%
Europe Developed 1.30%
Europe Emerging 0.00%
Africa/Middle East 0.00%
Greater Asia 0.00%
Japan 0.00%
Australasia 0.00%
Asia Developed 0.00%
Asia Emerging 0.00%
Market Classification
% Developed Markets 100.0%
% Emerging Markets 0.00%
As of July 24, 2015
Region breakdown data is calculated by using the long position holdings of the portfolio.

XBI Stock Sector Exposure

Basic Materials 0.00%
Communication Services 0.00%
Consumer Cyclical 0.00%
Consumer Defensive 0.00%
Energy 0.00%
Financial Services 0.00%
Healthcare 100.0%
Industrials 0.00%
Real Estate 0.00%
Technology 0.00%
Utilities 0.00%
As of July 24, 2015

XBI Stock Market Capitalization

Giant 3.64%
Large 5.07%
Medium 16.93%
Small 41.94%
Micro 32.34%
As of July 24, 2015
View More Holdings

XBI Top 10 Holdings

Name % Weight Price % Chg
Anacor Pharmaceuticals Inc 1.94% 150.31 -0.66%
Radius Health Inc 1.44% 73.41 +0.70%
Exelixis Inc 1.43% 5.59 +3.33%
Prothena Corp PLC 1.30% 66.85 -2.69%
Progenics Pharmaceuticals Inc 1.29% 8.425 -10.56%
Dynavax Technologies Corp 1.27% 29.65 +2.84%
Ophthotech Corp 1.27% 67.06 -1.44%
KYTHERA Biopharmaceuticals Inc 1.27% 74.41 -0.15%
Ultragenyx Pharmaceutical Inc 1.24% 116.48 -3.42%
Novavax Inc 1.22% 11.94 -2.09%
As of July 27, 2015
Advertisement

XBI Basic Info

Style
Equity Style Small Cap/Growth
Broad Asset Class Sector Equity
Broad Category Equity
Prospectus Objective Specialty - Health
Fund Owner Firm Name SPDR State Street Global Advisors
Benchmark Index
S&P Biotechnology Select Industry TR USD 100.0%

XBI Manager Info

Name Tenure
John Tucker 9.25 yrs
Karl Schneider 0.50 yrs
Michael Feehily 3.50 yrs

XBI Risk Info

Beta 1.037
Max Drawdown (All) 37.69%
Historical Sharpe (10y) --
Historical Sortino (All) 1.475
30-Day Rolling Volatility 32.49%
Daily Value at Risk (VaR) 1% (All) 4.61%
Monthly Value at Risk (VaR) 1% (All) 19.38%

XBI Fundamentals

Dividend Yield TTM (7-29-15) 0.69%
Weighted Average PE Ratio --
Weighted Average Price to Sales Ratio 13.01
Weighted Average Price to Book Ratio 7.244
Weighted Median ROE -24.02%
Weighted Median ROA -22.51%
Forecasted Dividend Yield 0.03%
Forecasted PE Ratio 34.19
Forecasted Price to Sales Ratio 9.744
Forecasted Price to Book Ratio 6.331
Number of Holdings 104
As of July 24, 2015

XBI Growth Estimates

Forecasted 5 Yr Earnings Growth 16.70%
Forecasted Book Value Growth 8.51%
Forecasted Cash Flow Growth 22.41%
Forecasted Earnings Growth 17.41%
Forecasted Revenue Growth 2.63%
As of July 24, 2015

XBI Performance

  Returns Total Returns
1M 1.30% 1.30%
3M 16.61% 16.81%
6M 27.12% 27.48%
1Y 75.66% 77.24%
3Y 170.5% 175.8%
5Y 366.2% 375.2%
As of July 28, 2015

XBI Net Flows

1M 255.79M
3M 364.64M
6M 691.73M
YTD 691.73M
1Y 785.69M
3Y 822.96M
5Y 774.46M
As of June 30, 2015

XBI Attributes

Key Dates
Inception Date 1/31/2006
Last Annual Report Date 6/30/2014
Last Prospectus Date 2/3/2015
Attributes
Exchange Traded Share Yes
Exchange Traded Note No
Enhanced Index Fund No
Index Fund Yes
Inverse Fund No
Leveraged Fund No
Fund of Funds No
Currency Hedged Fund No
Synthetic Replication Fund No
Has Dividend Investment Plan Yes
General Availability
Available for Insurance Product No
Available for Retirement Plan No
Available for RRSP No
Advertisement

You've hit the 10 page limit on YCharts.

Experience the power of YCharts.
Start your Free 7-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}
Start your free 7-Day Trial.

{{root.upsell.info.button_text}} No credit card required.

Already a subscriber? Sign in.